| 5-Amino-2-methyl-N-(1R-naphthalen-1-yl-ethyl)benzamide |
5-Amino-2-methyl-N-(1R-naphthalen-1-yl-ethyl)benzamide |
1093070-16-6 |
| 3-Pyridinecarboxylic acid, 5-chloro-2-methyl- |
5-氯-2-甲基-3-吡啶羧酸 |
1092286-30-0 |
| Rac1 Inhibitor II |
Z62954982 |
1090893-12-1 |
| (1-(4-fluorophenyl)cyclopropyl)methanamine hydrochloride |
(1-(4-fluorophenyl)cyclopropyl)methanamine hydrochloride |
1209726-03-3 |
| Dafadine-A |
CS-1223 |
1065506-69-5 |
| (T-4)-[(1E,6E)-1,7-bis[4-(Dimethylamino)phenyl]-1,6-heptadiene-3,5-dionato-O3,O5]difluoroboron |
(T-4)-[(1E,6E)-1,7-bis[4-(Dimethylamino)phenyl]-1,6-heptadiene-3,5-dionato-O3,O5]difluoroboron |
1193447-34-5 |
| Dabrafenib Mesylate(GSK-2118436B) |
达帕菲尼甲磺酸盐 |
1195768-06-9 |
| 2-oxo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile |
5-氰基-7-氮杂吲哚-2-酮 |
1190321-76-6 |
| TAS-115 |
1190836-34-0 |
1190836-34-0 |
| ASLAN003 |
ASLAN003 |
1035688-66-4 |
| AEM1 |
AEM1 |
1030123-90-0 |
| CMP5 |
CMP5 |
1030021-40-9 |
| Suvorexant |
苏沃雷生 |
1030377-33-3 |
| ethyl 3-(2,6-dichlorophenyl)-5-cyclopropylisoxazole-4-carboxylate |
5-环丙基-3-(2,6-二氯苯基)异噁唑-4-羧酸乙酯 |
1020569-65-6 |
| N-[2-[6-[[(3,4-Dichlorophenyl)Methyl]aMino]-2-(4-Methoxyphenyl)-3-oxopyrido[2,3-b]pyrazin-4(3H)-yl]ethyl]-acetaMide |
N-[2-[6-[[(3,4-二氯苯基)甲基]氨基]-2-(4-甲氧基苯基)-3-氧代-3,4-二氢吡啶并[2,3-B]吡嗪-4-基]乙基]乙酰胺 |
1018674-83-3 |
| tert-butyl 2-chloro-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate |
2-氯-7,8-二氢-1,6-萘啶-6(5H)-羧酸叔丁酯 |
1151665-15-4 |
| 4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine |
4-(3-溴咪唑并[1,2-B]吡嗪-6-基)吗啉 |
1012343-72-4 |
| Thiamet GDiscontinued |
THIAMET G |
1009816-48-1 |
| LY-2562175 |
化合物LY2562175 |
1103500-20-4 |
| 4-Quinazolinamine, N-cyclohexyl-2-cyclopropyl- |
化合物TH1085 |
1002801-51-5 |
QQ
微信
